Enzo Biochem to Present at Lazard Capital Markets 7th Annual Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading vertically integrated clinical lab, life sciences and therapeutic biotechnology company, announced today that Barry Weiner, President, David Goldberg, Vice President, Corporate Development, and Andrew Crescenzo, Senior Vice President - Finance, will be presenting at the Lazard Capital Markets 7th Annual Healthcare Conference on Tuesday, November 16, 2010 at 4:40 PM at The St. Regis Hotel in New York, N.Y.
MORE ON THIS TOPIC